News

News

Press Release

Complement Therapeutics secures Innovate UK EDGE funding to collaborate with the Cell and Gene Therapy Catapult on regulatory strategy for CTx001

The Innovate UK EDGE grant funding is awarded to innovative companies looking to benefit from the expertise provided by Catapults...
Read More
Press Release

MHRA awards Complement Therapeutics Innovation Passport for CTx001 to accelerate Gene Therapy for Geographic Atrophy

MHRA granted Complement Therapeutics an Innovation Passport under the new accelerated Innovative Licensing and Access Pathway (ILAP)ILAP is designed to...
Read More
Press Release

Complement Therapeutics Announces the Establishment of its Clinical & Scientific Advisory Board

London, England – 27th September 2022 - Complement Therapeutics Ltd (CTx), a preclinical stage biotechnology company, today announced the formation...
Read More
Press Release

Complement Therapeutics Ltd announces appointment of Dr Dennis Keefe as Chief Scientific Officer

London, England – 10th August 2022 - Complement Therapeutics Ltd (CTx), a preclinical stage biotechnology company focused on the research...
Read More
Press Release

Complement Therapeutics Ltd announces appointment of Steve Axon to its Board of Directors

Complement Therapeutics Ltd announces appointment of Steve Axon to its Board of Directors London, England – 18th July 2022 -...
Read More
Press Release

Complement Therapeutics Ltd raises EUR 5 Million Seed Financing by BGV and Forbion and appoints Dr Rafiq Hasan as CEO

Next-generation Complement Therapeutics based on the role of Factor H-related proteins in complement-mediated diseases Company emerges out of stealth mode...
Read More

4th Floor, Central Working White City
Translation and Innovation Hub
84 Wood Lane
London, W12 0BZ
United Kingdom


Created by HTP Digital